These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 30928481

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The use of anti-IgE therapy beyond allergic asthma.
    Stokes JR, Casale TB.
    J Allergy Clin Immunol Pract; 2015; 3(2):162-6. PubMed ID: 25609342
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Omalizumab versus intranasal steroids in the post-operative management of patients with allergic fungal rhinosinusitis.
    Mostafa BE, Fadel M, Mohammed MA, Hamdi TAH, Askoura AM.
    Eur Arch Otorhinolaryngol; 2020 Jan; 277(1):121-128. PubMed ID: 31552526
    [Abstract] [Full Text] [Related]

  • 8. Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
    Gevaert P, Mullol J, Saenz R, Ko J, Steinke JW, Millette LA, Meltzer EO.
    Ann Allergy Asthma Immunol; 2024 Mar; 132(3):355-362.e1. PubMed ID: 37951571
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.
    Navinés-Ferrer A, Serrano-Candelas E, Molina-Molina GJ, Martín M.
    J Immunol Res; 2016 Mar; 2016():8163803. PubMed ID: 28097159
    [Abstract] [Full Text] [Related]

  • 11. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
    D'Amato G, Piccolo A, Salzillo A, Noschese P, D'Amato M, Liccardi G.
    Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):225-31. PubMed ID: 19075985
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.
    Kim DH, Park KY, Kim BJ, Kim MN, Mun SK.
    Clin Exp Dermatol; 2013 Jul; 38(5):496-500. PubMed ID: 23083013
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term omalizumab efficacy in allergic rhinitis.
    Cavaliere C, Begvarfaj E, Incorvaia C, Sposato B, Brunori M, Ciofalo A, Greco A, de Vincentiis M, Masieri S.
    Immunol Lett; 2020 Nov; 227():81-87. PubMed ID: 32798500
    [Abstract] [Full Text] [Related]

  • 20. Omalizumab in children with severe allergic disease: a case series.
    Crisafulli G, Caminiti L, Chiera F, Arasi S, Salzano G, Panasiti I, Barbalace A, Pajno GB.
    Ital J Pediatr; 2019 Jan 14; 45(1):13. PubMed ID: 30642367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.